Bio21 Institute
30 Flemington Road
Parkville, VIC 3010
Australia
61 3 8256 2880
https://www.rhythmbio.com
Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD | Executive Chairman | 111,98k | N/D | 1964 |
Mr. Guy Carisbrooke | Financial Controller | N/D | N/D | N/D |
Ms. Andrea Steele LLB B Com LLM | General Counsel & Joint Company Secretary | N/D | N/D | N/D |
Ms. Elena Deak | Chief Commercial Officer | N/D | N/D | N/D |
Mr. James Stephen Barrie CPA | Joint Company Secretary | N/D | N/D | N/D |
Rhythm Biosciences Limited, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
L'ISS Governance QualityScore di Rhythm Biosciences Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.